OPTIC: Views on OPTimising Immune Checkpoint inhibition in cancer
Share this page:
The researchers for the OPTIC trial have conducted online discussion groups with kidney cancer patients and carers to talk about their views on the way that immunotherapy medicines are given for cancer. These views could help shape future cancer research trials. Thank you to those of you who took part in these discussion groups.
We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.
Registered charity in England, Wales (1164238), and Scotland (SC051330).